| Members |
targetComponentId |
| Tendinit i musculus tibialis anticus |
Tibialis anterior tendinitis |
| Ruptur af musculus tibialis posterior |
Rupture of tibialis posterior tendon (disorder) |
| Tibiofibular ligament (& distal) |
Structure of ligament of distal tibiofibular joint |
| Tic |
Tic disorder |
| Tic |
Tic (finding) |
| Tic |
Tic (finding) |
| Tic |
Tic disorder |
| Tic |
Tic (finding) |
| Tic |
Tic disorder |
| Tic disorder |
Tic (finding) |
| Tic disorder |
Tic disorder |
| bivirkning af ticarcillin og clavulansyre |
Adverse reaction to clavulanic acid and/or ticarcillin |
| Ticarcillin disodium with clavulanate potassium |
Clavulanate potassium (substance) |
| Ticarcillin disodium with clavulanate potassium |
Ticarcillin disodium (substance) |
| flåtbid uden infektion |
Bite of tick (event) |
| flåtbid uden infektion |
Tick bite |
| flåtoverført lammelse medførende toksisk virkning |
Tick paralysis |
| Tick-borne bunyavirus encephalitis |
Nairoviral encephalitis (disorder) |
| Tick-borne bunyavirus fever |
Tick-borne orthobunyavirus fever |
| Tick-borne bunyavirus fever |
Disease caused by Nairovirus (disorder) |
| tick-borne encephalitis-vaccine |
Tick-borne encephalitis virus antigen-containing vaccine product |
| vaccine mod flåtoverført encephalitis |
Tick-borne encephalitis virus antigen-containing vaccine product |
| tick-borne encephalitis-vaccine injektionsvæske, opløsning i fyldt injektionssprøjte |
Tick-borne encephalitis virus antigen-containing vaccine product |
| Tick-borne flavivirus encephalitis |
Tick-borne encephalitis |
| Tick-borne flavivirus encephalitis |
Encephalitis due to tick-borne encephalitis virus subgroup |
| Tick-borne viral encephalitis |
Viral encephalitis transmitted by tick |
| Tick-borne viral encephalitis |
Tick-borne encephalitis |
| Tickle sensation, function (observable entity) |
Ability to sense tickle (observable entity) |
| Tickle sensation, function (observable entity) |
Tickle sensation, function (observable entity) |
| Tidal river |
Tidal river (environment) |
| Tidal river |
Tidal river water (substance) |
| Tile &/or slab caster |
Tile caster |
| Tile &/or slab caster |
Tile/slab caster |
| Tile &/or slab caster |
Slab caster (occupation) |
| Tile &/or slab caster |
Slab caster (occupation) |
| Tile &/or slab caster |
Tile/slab caster |
| Tiler |
Tiler |
| Tiler |
Floor/wall tiler |
| Tiler |
Floor/wall tiler |
| Tiler |
Tiler |
| Time duration (property) (qualifier value) |
Time (property) (qualifier value) |
| Time duration (property) (qualifier value) |
Time (attribute) |
| Timed six meter walk |
Timed six meter walk time (observable entity) |
| Timed six meter walk |
Timed six metre walk technique |
| Timolol 0.1% liquid eye gel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
| timolol 0,1% flydende øjengel |
Timolol (as timolol maleate) 1 mg/mL eye gel |
| timolol 0,25% flydende øjengel |
Timolol (as timolol maleate) 2.5 mg/mL eye gel |
| timolol 0,5 % øjendråber uden konserveringsmiddel |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
| timolol 0,5% flydende øjengel |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye gel (clinical drug) |
| Timothy grass |
Phleum pratense (organism) |
| Timothy grass |
Phleum |
| Timothy grass pollen allergen |
Timothy grass pollen |
| Tinamou |
Order Tinamiformes (organism) |
| Tinamou |
Family Tinamidae (organism) |
| Tinea barbae |
Tinea barbae (disorder) |
| Tinea barbae |
Deep bacterial folliculitis (disorder) |
| Tinea barbae |
Bacterial folliculitis (disorder) |
| Tinea barbae |
Pseudofolliculitis barbae (disorder) |
| Tinea cruris |
Tinea of perianal region (disorder) |
| Tinea cruris |
Tinea cruris (disorder) |
| Tinea nigra |
Tinea nigra |
| Tinea nigra |
Infection by Cladosporium werneckii |
| Tinea nigra |
Microsporosis nigra |
| Tinea pedis forårsaget af kombineret/samtidig infektion |
Tinea pedis |
| Tinea profunda |
Tinea profunda |
| Tinea profunda |
Deep seated dermatophytosis |
| Tinea unguium |
Onychomycosis (disorder) |
| Tinea unguium |
Onychomycosis due to dermatophyte |
| Tingling: [sensation] or [has sensation] |
Tingling of skin |
| Tingling: [sensation] or [has sensation] |
Tingling of skin |
| tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,25 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,35 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,45 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 10.000 IE/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Product containing precisely tinzaparin sodium 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,7 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,9 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tinzaparinnatrium 20.000 IE/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Product containing precisely tinzaparin sodium 20000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| tioconazol 28 % opløsning |
Tioconazole 283 mg/mL cutaneous solution |
| Tissierella-art |
Tissierella |
| prøve af vævscelle |
Cytologic material |
| teknik til frysesnit af væv, komplet |
Tissue frozen section technique |
| Tissue saturation oximeter sensor, reprocessed |
Oxygen sensor (physical object) |
| Tissue saturation oximeter sensor, single-use |
Oxygen sensor (physical object) |
| Tissue specimen from lung |
Specimen from lung obtained by biopsy |
| Tissue specimen from lung |
Tissue specimen from lung (specimen) |
| Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Non-smoker |
| Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Non-smoker |
| Tobacco consumption: [non-smoker] or [smoker - amount smoked] |
Tobacco smoking consumption |
| Tobacco dependence (& [dependent smoker]) |
Tobacco dependence syndrome (disorder) |
| Kælkedermatitis |
Frictional lichenoid eruption (disorder) |
| Kælkedermatitis |
Friction dermatitis of children |
| tobramycin 40 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| tobramycin 40 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tobramycin [eye] |
Product containing tobramycin in ocular dose form (medicinal product form) |
| Tobramycin [respiratory use] |
Product containing tobramycin in pulmonary dose form (medicinal product form) |
| Toe: [Perionychia] or [cellulitis and abscess NOS] |
Onychia of toe (disorder) |
| Toe: [Perionychia] or [cellulitis and abscess NOS] |
Paronychia of toe (disorder) |
| Toe: [cellulitis] or [paronychia] |
Cellulitis of toe |
| Toe: [cellulitis] or [paronychia] |
Paronychia of toe (disorder) |
| Toe: [cellulitis] or [paronychia] |
Onychia of toe (disorder) |
FHIR